Cambridge Trust’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $55K | Hold |
2,000
| – | – | ﹤0.01% | 412 |
|
|
2023
Q4 | $61K | Hold |
2,000
| – | – | ﹤0.01% | 401 |
|
|
2023
Q3 | $63.2K | Sell |
2,000
-1,322
| -40% | -$41.8K | ﹤0.01% | 391 |
|
|
2023
Q2 | $135K | Hold |
3,322
| – | – | 0.01% | 322 |
|
|
2023
Q1 | $124K | Hold |
3,322
| – | – | 0.01% | 334 |
|
|
2022
Q4 | $116K | Hold |
3,322
| – | – | 0.01% | 341 |
|
|
2022
Q3 | $186K | Hold |
3,322
| – | – | 0.01% | 288 |
|
|
2022
Q2 | $172K | Hold |
3,322
| – | – | 0.01% | 316 |
|
|
2022
Q1 | $241K | Hold |
3,322
| – | – | 0.01% | 309 |
|
|
2021
Q4 | $392K | Buy |
+3,322
| New | +$392K | 0.01% | 252 |
|
|
2021
Q3 | – | Sell |
-1,322
| Closed | -$214K | – | 277 |
|
|
2021
Q2 | $214K | Buy |
+1,322
| New | +$214K | 0.01% | 263 |
|